首页> 中文期刊> 《中外医学研究》 >胃苏颗粒联合西药对老年慢性胃炎患者疗效和生存质量的影响

胃苏颗粒联合西药对老年慢性胃炎患者疗效和生存质量的影响

         

摘要

Objective:To discuss and analyze the clinical effect and impact of Weisu Granula combined with western medicine on life quality of senile patients with chronic gastritis.Method:64 cases conformed to criteria were chosen and divided into treatment group and control group each with 32 cases according to different treatment methods.The control group was treated with western medicine(Amoxicillin+Omeprazole),while the treatment group was treated with Weisu Granula combined with western medicine(Amoxicillin+Omeprazole). Clinical effect and life quality of two groups were observed.Result:Conditions of both groups were improved,but the total effective rate of the treatment group was 90.6%,it was obviously higher than the control group’s 68.8%(P<0.05).Life quality of both groups were improved after treatment,but the treatment group was obviously superior to the control group on body function,body pain,overall health,life vitality,social function and mental health(P<0.05).Conclusion:Weisu Granula combined with western medicine for treatment of senile chronic gastritis can effectively relieve pain of patients,and improve their life quality and living standard.It has a significant effect and is worth of being popularized.%目的:探析老年慢性胃炎患者采用胃苏颗粒联合西药治疗的临床效果及对生存质量的影响。方法:入选笔者所在医院符合胃炎诊断标准的患者64例,按治疗方式的不同分为治疗组和对照组,每组32例。对照组患者给予西药(阿莫西林+奥美拉唑)治疗,治疗组患者给予胃苏颗粒联合西药(阿莫西林+奥美拉唑)治疗;观察两组患者治疗后的临床效果及生存质量情况。结果:两组治疗后病情均有改善,但治疗组总有效率为90.6%,明显优于对照组的68.8%,差异有统计学意义(P<0.05);两组患者治疗后生存质量均有改善,但治疗组躯体职能、躯体疼痛、总体的健康、生命活力、社交功能、心理健康六个方面的评分情况显著优于对照组,差异有统计学意义(P<0.05)。结论:老年慢性胃炎患者采用胃苏颗粒联合西药治疗,有效缓解了患者的临床痛苦,改善了患者的生存质量,提高了患者的生活水平,效果显著,值得推广。

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号